CLINICAL_TRIALS
trial_result
· 2019-01-08
Clinical Trial Update: Tivozanib for Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 clinical trial update for tivozanib in recurrent glioblastoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08